Timothy Norris
18Patents
6h-index
29Co-inventors
58Inventor score
Filing activity: Oct 7, 1996 → Nov 18, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6476040B1 | Processes and intermediates for preparing anti-cancer compounds | Emerging Cross-Sectional Technologies | 69 | Expired |
| US6900221B1 | Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof | Chemistry; Metallurgy | 40 | Expired |
| US7087613B2 | Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride | Human Necessities | 20 | Expired |
| US6159976A | Polymorph of zopolrestat monohydrate | Human Necessities | 13 | Expired |
| US6262067A | Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions | Human Necessities | 10 | Expired |
| US5763454A | Crystal form of anhydrous 7-(1.alpha.,5.alpha.,6.alpha.!-6-amino-3-azabicyclo3.1.0!hex-3-yl)-6-f luoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt | Human Necessities | 8 | Expired |
| US6706721B1 | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | Chemistry; Metallurgy | 4 | Expired |
| US6239285A | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Chemistry; Metallurgy | 2 | Expired |
| US6066647A | Zwitterionic forms of trovafloxacin | Human Necessities | 2 | Expired |
| US6346624B1 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Chemistry; Metallurgy | 1 | Expired |
| US6114531A | Process for preparing quinolone and naphthyridone carboxylic acids | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7521456B2 | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | Chemistry; Metallurgy | 1 | Expired |
| US5929240A | Process and intermediates for preparing naphthyridonecarboxylic acid salts | Chemistry; Metallurgy | 1 | Expired |
| US6344563B1 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Chemistry; Metallurgy | 0 | Expired |
| US6359137B1 | Process for preparing trovafloxacin acid salts | Chemistry; Metallurgy | 0 | Expired |
| US7019009B2 | Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity | Human Necessities | 0 | Expired |
| US6753334B2 | Preparation of sodium-hydrogen exchanger type-1 inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US6080756A | Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.